Ubenimex (also known as bestatin) is a competitive protease inhibitor. It is an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N. It is being studied for use in the treatment of acute myelocytic leukemia. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Bestatin and Ubenimexum. Its PubChem CID is 72172.
Ubenimex
| CAS No | 58970-76-6 |
|---|---|
| Molecular Formula | C16H24N2O4 |
| Molecular Weight | 308.37 g/mol |
| Synonyms | (2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ubenimex (also known as bestatin) is a competitive protease inhibitor. It is an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N. It is being studied for use in the treatment of acute myelocytic leukemia.
The listed CAS number is 58970-76-6.
The listed molecular formula is C16H24N2O4.
The listed molecular weight is 308.37 g/mol.
(2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoic acid.
The source lists Bestatin and Ubenimexum.